Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
14/05/2026 08:48
May 14 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS: CAPLIN POINT LABORATORIES LTD - DECLARES INTERIM DIVIDEND OF 4 RUPEES PER SHARE FOR FY ENDED MARCH 31, 2026 CAPLIN POINT LABORATORIES MARCH-QUARTER CONSOL NET PROFIT 1.7 BILLION RUPEES CAPLIN POINT LABORATORIES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 6 BILLION RUPEES Source text: ID:nBSE3bz32j Further company coverage: CAPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees